- cafead Oct 24, 2023 at 10:12: AM
via Rampart Biosciences is working on an experimental treatment to compete with Alexion Pharmaceuticals’ Strensiq, which treats hypophosphatasia.
article source
article source
-
Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page
An Orbimed-backed biotech launches with $85M and plans for a new kind of DNA medicine
- Thread starter cafead
- Start date
<
Similar threads